Earnix Delivers on Promise of AI with Intelligent Decisioning Platform
At its Excelerate 2025 conference, Earnix, the leader in Dynamic AI for insurance, announced a new suite of solutions designed to help insurers fully realise the promise of AI. Built specifically for the insurance industry, these technologies accelerate decision-making and improve personalised customer experiences all while ensuring compliance in complex regulatory environments.
For insurers, these Intelligent Decisioning capabilities unlock smarter, data-driven decision-making at scale. The platform delivers real-time insights and personalised offerings with faster speed-to-market, while maintaining robust governance of automated decisions. Customers benefit from:
- Improved profitability and risk management
- Stronger regulatory compliance and governance
- Enhanced customer satisfaction through personalised engagement
- Greater competitive positioning in a rapidly changing landscape
The unified, no-code/low-code intelligent decisioning platform empowers business users to innovate rapidly without relying on IT teams. It enables insurers to adapt quickly to market shifts, launch new products faster, and optimise pricing strategies with confidence. Seamless data integration, embedded compliance and explainability, and out-of-the-box connectivity with core systems and engagement channels ensure insurers can operate effectively even in heavily regulated settings.
Intelligent Decisioning
Earnix’s Intelligent Decisioning Platform is underpinned by Earnix’s robust data and Dynamic AI capabilities, unifying predictive, generative, and agentic AI capabilities with governed workflows so teams can act quickly and confidently and launch innovative products without compromising security, compliance, or control.
Intelligent Decisioning Solution Enhancements Announced Today:
- Earnix’s AI Studio: Earnix’s AI Studio is a purpose-built intelligent decisioning solution designed for the insurance industry. It allows carriers to seamlessly create, manage, and deploy agentic AI within decisioning workflows, supported by an intuitive no-code/low-code environment and a catalog that governs versioning, authorisation, and control. Embedded guardrails ensure each agent operates within defined policies, while built-in testing capabilities verify reliability before deployment. With these safeguards, insurers can embed agents into their operations with confidence, ensuring governance, transparency, and trust at scale.
- Elevate Data: Elevate Data is a unified, governed data layer for Dynamic AI that addresses growing data complexity. It provides seamless integration with major data lake providers, including AWS, Snowflake, and Databricks, and offers AI-driven ETL (extract, transform, load) capabilities. It empowers carriers to ingest, transform, and manage both proprietary and third-party data at scale, enabling better model development and faster, more informed decisioning directly aligned with regulatory standards and operational needs.
- Customer Engagement Capabilities: Earnix’s Customer Engagement Platform leverages advanced AI to enhance front-line interactions by delivering personalised, next-best-action recommendations to agents and digital channels. The solution interacts with vertical solutions across the decisioning journey to empower sales and service teams with contextual insights, improving customer experiences, accelerating conversion, and driving revenue growth.
“The insurance industry is evolving at record speed. Changing risks, regulatory pressures, and the demand for more personalised service mean that carriers must anticipate - and enable - what’s next,” said Robin Gilthorpe, CEO at Earnix. “Our intelligent decisioning platform is purpose-built for this moment. It brings together the power of predictive, generative and agentic AI, underpinned by robust governance, and positions clients to deliver exceptional value in every market they serve.”
“The promise of AI in insurance comes with challenges - governance, compliance, and trust are non-negotiable in our industry,” commented Be’eri Mart, Chief Product Officer at Earnix. “Our AI capabilities empower carriers to operationalise agentic AI seamlessly within decisioning workflows, while embedding the insurance-specific guardrails needed to ensure reliability. This combination unlocks the ability to scale innovation responsibly, transforming underwriting, pricing, and beyond into transparent, agile, and future-ready operations.”
“Insurers today face mounting pressure to modernise their operations while harnessing the full power of their data and analytics investments. Solutions like Earnix's can help insurers embed advanced AI and automation directly into core processes - enabling organisations to accelerate innovation, improve risk assessment, and respond to changing market demands with far greater agility,” explained Keith Raymond, Principal Analyst at Celent. “These advancements not only drive operational efficiency but also lay the foundation for more personalised and responsive customer experiences across the value chain.”
About Earnix
Earnix is the premier provider of mission-critical, intelligent decisioning across pricing, underwriting, rating, and product personalisation. Its fully integrated platform provides ultra-fast ROI and is designed to transform how global insurers and banks are run by unlocking value across all facets of the business. Earnix has been innovating for insurers and banks since 2001, with customers in over 35 countries across six continents and offices in the Americas, Europe, Asia Pacific, and Israel. Earnix is backed by investors JVP and Insight Partners.
To learn more, visit: www.earnix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250910322722/en/
Contacts
Media Contact:
Paul Dobson-Brunell
Director of Communications, Earnix
press@earnix.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Expands Capabilities in Asia Pacific with VDB Loi10.9.2025 16:30:00 EEST | Press release
Andersen Consulting broadens its capabilities in Cambodia, Vietnam, and Laos as VDB Loi brings consulting capabilities to its existing tax and legal offering. Led by Managing Director Jean Loi, who also serves as managing director for Andersen in Cambodia and Vietnam, VDB Loi was founded in 2012 as a tax and legal firm and has been a collaborating firm of Andersen Global since 2021. With the addition of its full suite of consulting services, VDB Loi is now a member of Andersen Consulting offering comprehensive solutions in business strategy, AI, technology transformation, and cybersecurity to complement its existing tax and legal platform. “We have been a part of the Andersen family for several years now and recognize the value and synergy this multidisciplinary approach provides for our clients,” Jean said. “In our current business landscape, it is not enough to be solely a tax firm or solely a legal firm as a single service offering does not effectively cover clients’ overall busines
INNORNA Completes Phase II Enrollment and Vaccination of Bivalent RSV mRNA Vaccine IN00610.9.2025 16:21:00 EEST | Press release
Innorna today announced the completion of enrollment and vaccination in its Phase II clinical trial for IN006, the world’s first bivalent respiratory syncytial virus (RSV) mRNA vaccine currently in development by the company. IN006 is also China's first domestically developed RSV vaccine to enter clinical trials, following IND approval in June 2024. The Phase I trial began with the first subject vaccinated in November 2024. Completion of enrollment and dosing in Phase II marks a milestone toward dose optimization and sets the stage for Phase III efficacy studies. The Phase II study is a randomized, double-blind, placebo-controlled trial conducted in China among healthy adults aged 60 and above. Key study objectives include dose optimization, broader population validation, and booster evaluation for annual revaccination. “This Phase II clinical trial marks a critical step in validating IN006’s scientific hypothesis—delivering broad-spectrum, durable protection against RSV,” said Dr. Lin
Xsolla Web Shop and Singular Join Forces to Deliver Cross-Platform LTV and ROAS Measurement Solutions10.9.2025 16:00:00 EEST | Press release
Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced a new mobile-focused Server-to-Server (S2S) integration with Singular, a leading marketing analytics and attribution platform. The integration unifies mobile marketing data with direct-to-consumer web purchases, enabling developers to measure campaign performance and player value more accurately than ever before. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910813948/en/ Graphic: Xsolla As mobile game makers increasingly turn to Web Shops to expand revenue streams beyond app stores, one challenge has persisted: how to tie those off-platform transactions back to mobile marketing spend. The Xsolla Web Shop + Singular S2S integration closes this gap by treating Web Shop purchases as attributable events, giving developers true Return on Advertising Spend (ROAS) and comprehensive Lifetime Value (LTV) ins
Veritas Capital Closes Ninth Flagship Fund at Hard Cap of $14.4 Billion10.9.2025 16:00:00 EEST | Press release
Veritas Capital (“Veritas”), a leading investor at the intersection of technology and government, today announced the final close of The Veritas Capital Fund IX (“Fund IX”) with $14.4 billion in aggregate capital commitments. Fund IX was significantly oversubscribed, with demand exceeding the hard cap and surpassing the initial target of $13 billion. The fundraise represents a 35% increase over Fund VIII which closed at $10.7 billion in 2022. With the close of Fund IX, Veritas now manages more than $54 billion in assets across its strategies, strengthening its position as a leading investor focused on technology. “Fund IX represents an important step forward for Veritas, and I’m deeply proud of our team and the enduring partnerships that made this milestone possible,” said Ramzi Musallam, Chief Executive Officer and Managing Partner of Veritas. “In one of the most challenging fundraising environments in recent memory, strong demand for Fund IX is a clear endorsement of our strategy and
INTRESO's New Fumigation Treatment Approved in U.S. as a High-Efficacy Alternative to the Damaging Methyl Bromide10.9.2025 16:00:00 EEST | Press release
International Treatment Solutions (INTRESO) Group is pleased to announce the registration of eFUME® by the U.S. Environmental Protection Agency (EPA). The registration marks an important milestone for the U.S. agricultural sector in safeguarding its supply chains and biosecurity. eFUME® is a fast-acting, safe, and effective solution for protecting post-harvest produce, packaged and stored foods, and processing equipment. Suited to a wide variety of fruits, vegetables, grains, and cut flowers, its active ingredient, ethyl formate, is a naturally occurring substance. It is regarded as safe for human health by the U.S. Food and Drug Administration (FDA), yet rapidly and effectively eliminates insect pests, typically within one to 24 hours, resulting in no withholding period and faster shipping. Designed for broad applications, eFUME® is effective against stored product insects, fresh produce pests, mites, quarantine pests of concern, and household insects. It is already registered and wid
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom